Åke Lernmark at Lund University - Research Interests, Publications & Academic Profile

Åke Lernmark

Lund University

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

100%

Internal Medicine

40%

Diabetology

100%

Islet Biology

100%

Autoimmunity

100%

Pediatric Endocrinology

70%

Insulin

50%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

Article Link

Year:

2024

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

Article Link

Year:

2024

Caesarean section and risk of type 1 diabetes

Article Link

Year:

2024

Joint modeling of multistate and nonparametric multivariate longitudinal data

Article Link

Year:

2024

Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk

Article Link

Year:

2024

Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)

Article Link

Year:

2024

The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study

Article Link

Year:

2024

Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays

Article Link

Year:

2024

HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)

Article Link

Year:

2024

Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study

Article Link

Year:

2024

Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Article Link

Year:

2023

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Article Link

Year:

2023

Gastrointestinal Infections Modulate the Risk for Insulin Autoantibodies as the First-Appearing Autoantibody in the TEDDY Study

Article Link

Year:

2023

HLA Genotype and Probiotics Modify the Association Between Timing of Solid Food Introduction and Islet Autoimmunity in the TEDDY Study

Article Link

Year:

2023

SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens

Article Link

Year:

2023

Possible heterogeneity of initial pancreatic islet beta‐cell autoimmunity heralding type 1 diabetes

Article Link

Year:

2023

Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5- to 15-Year-Old Children Followed in the TEDDY Study

Article Link

Year:

2023

Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood

Article Link

Year:

2023

Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload

Article Link

Year:

2023

Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity

Article Link

Year:

2023

Collaborators6

M. Sue Kirkman

University of North Carolina

UNITED STATES

View Details

Rachel Besser

Honorary senior clinical lecturer

UNITED KINGDOM

View Details

Suvi Virtanen

Research Professor

FINLAND

View Details

Ezio Bonifacio

W3 Professor Pre-Clinical Stem Cells

Technische Universität Dresden

GERMANY

View Details

Markus Mattila

University of Tampere

FINLAND

View Details

george bakris

Professor of medicine, Director AHA Comprehensive Hypertension Center

University of Chicago

UNITED STATES

View Details

How do I reach out?

Continue in dashboard